Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ArriVent BioPharma, Inc. - Common Stock (NQ: AVBP ) 24.36 +0.50 (+2.10%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 93,354 Open 24.19 Bid (Size) 16.20 (2) Ask (Size) 39.45 (2) Prev. Close 23.86 Today's Range 23.45 - 24.97 52wk Range 14.35 - 25.95 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AVBP Stock Earnings: ArriVent BioPharma Misses EPS for Q2 2024 August 14, 2024 AVBP stock results show that ArriVent BioPharma missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million June 08, 2024 Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent... Via Talk Markets Performance YTD +21.80% +21.80% 1 Month +23.97% +23.97% 3 Month +21.19% +21.19% 6 Month +8.41% +8.41% 1 Year +21.80% +21.80% More News Read More AVBP Stock Earnings: ArriVent BioPharma Beats EPS for Q1 2024 May 08, 2024 Via InvestorPlace ArriVent BioPharma Reports First Quarter 2024 Financial Results May 08, 2024 From ArriVent BioPharma, Inc. Via GlobeNewswire ArriVent Appoints Kristine Peterson to its Board of Directors April 22, 2024 From ArriVent BioPharma, Inc. Via GlobeNewswire ProfoundBio Discovers The Joys Of Having A Wealthy Owner April 08, 2024 Via Benzinga Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal March 30, 2024 Via Talk Markets $10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying February 02, 2024 Via Benzinga KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower January 28, 2024 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China January 27, 2024 Via Talk Markets Topics Initial Public Offering Exposures Securities Market Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
